Literature DB >> 3925740

Propylene glycol-induced heparin resistance during nitroglycerin infusion.

J Col, C Col-Debeys, E Lavenne-Pardonge, P Meert, L Hericks, M C Broze, M Moriau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3925740     DOI： 10.1016/0002-8703(85)90534-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  8 in total

Review 1.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

Review 2.  Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs.

Authors:  J C DeToledo; R E Ramsay
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

3.  The effect of different nitrate preparations on plasma heparin concentrations and the activated partial thromboplastin time.

Authors:  M J Brack; R S More; P J Hubner; A H Gershlick
Journal:  Postgrad Med J       Date:  1994-02       Impact factor: 2.401

Review 4.  [Heparin resistance and antithrombin deficiency].

Authors:  Norbert Maurin
Journal:  Med Klin (Munich)       Date:  2009-06-16

5.  Propylene glycol-induced side effects during intravenous nitroglycerin therapy.

Authors:  H E Demey; R A Daelemans; G A Verpooten; M E De Broe; C M Van Campenhout; F V Lakiere; P J Schepens; L L Bossaert
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

Review 6.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

7.  Hemodynamic effects of SIN-1 in acute left heart failure.

Authors:  T M Ibrahim; P H Unger; J Sobolski; P Depelchin; M Jottrand; S Degre
Journal:  Cardiovasc Drugs Ther       Date:  1989-08       Impact factor: 3.727

Review 8.  Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.

Authors:  M Verstraete
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.